title: Virtual electrophysiological study of atrial fibrillation in fibrotic remodeling.
abstract: Research has indicated that atrial fibrillation (AF) ablation failure is related to the presence of atrial fibrosis. However it remains unclear whether this information can be successfully used in predicting the optimal ablation targets for AF termination. We aimed to provide a proof-of-concept that patient-specific virtual electrophysiological study that combines i) atrial structure and fibrosis distribution from clinical MRI and ii) modeling of atrial electrophysiology, could be used to predict: (1) how fibrosis distribution determines the locations from which paced beats degrade into AF; (2) the dynamic behavior of persistent AF rotors; and (3) the optimal ablation targets in each patient. Four MRI-based patient-specific models of fibrotic left atria were generated, ranging in fibrosis amount. Virtual electrophysiological studies were performed in these models, and where AF was inducible, the dynamics of AF were used to determine the ablation locations that render AF non-inducible. In 2 of the 4 models patient-specific models AF was induced; in these models the distance between a given pacing location and the closest fibrotic region determined whether AF was inducible from that particular location, with only the mid-range distances resulting in arrhythmia. Phase singularities of persistent rotors were found to move within restricted regions of tissue, which were independent of the pacing location from which AF was induced. Electrophysiological sensitivity analysis demonstrated that these regions changed little with variations in electrophysiological parameters. Patient-specific distribution of fibrosis was thus found to be a critical component of AF initiation and maintenance. When the restricted regions encompassing the meander of the persistent phase singularities were modeled as ablation lesions, AF could no longer be induced. The study demonstrates that a patient-specific modeling approach to identify non-invasively AF ablation targets prior to the clinical procedure is feasible.
authors.affiliation: The Johns Hopkins University, Department of Biomedical Engineering, Baltimore, Maryland, United States of America.
authors.forename: Kathleen S
authors.initials: KS
authors.lastname: McDowell
authors.affiliation: The Johns Hopkins University, Department of Biomedical Engineering, Baltimore, Maryland, United States of America.
authors.forename: Sohail
authors.initials: S
authors.lastname: Zahid
authors.affiliation: The Johns Hopkins University, Department of Biomedical Engineering, Baltimore, Maryland, United States of America.
authors.forename: Fijoy
authors.initials: F
authors.lastname: Vadakkumpadan
authors.affiliation: University of Utah, Comprehensive Arrhythmia Research and Management Center, School of Medicine, Salt Lake City, Utah, United States of America.
authors.forename: Joshua
authors.initials: J
authors.lastname: Blauer
authors.affiliation: University of Utah, Comprehensive Arrhythmia Research and Management Center, School of Medicine, Salt Lake City, Utah, United States of America.
authors.forename: Rob S
authors.initials: RS
authors.lastname: MacLeod
authors.affiliation: The Johns Hopkins University, Department of Biomedical Engineering, Baltimore, Maryland, United States of America.
authors.forename: Natalia A
authors.initials: NA
authors.lastname: Trayanova
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy; D002318:Cardiovascular Diseases / Q000473:pathology / Q000503:physiopathology; D017115:Catheter Ablation; D022062:Electrophysiologic Techniques, Cardiac / Q000379:methods*; D005260:Female; D005355:Fibrosis / Q000473:pathology / Q000503:physiopathology; D006325:Heart Atria / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged